Vaxxinity rises on smaller quarterly loss

Vaxxinity

09/05/2022 14:01

** Biotech company's shares  VAXX.O  up 3.4% at $5.70
premarket
    ** Company reports Q1 net loss of $18.3 mln vs loss of $32.0
mln a year earlier  urn:newsml:reuters.com:*:nGNX5jcFP9
    ** VAXX looks forward to initiating its human trial of
migraine vaccine candidate - CEO Mei Mei Hu
    ** Stock down nearly 2% YTD as of last close

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com; Twitter: https://twitter.com/LeroyLeo7))